SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001513162-18-000248
Filing Date
2018-10-01
Accepted
2018-10-02 10:44:55
Documents
9
Effectiveness Date
2018-10-01

Document Format Files

Seq Description Document Type Size
1 FORM S-8 forms8.htm S-8 447916
2 EXHIBIT 4.13 exhibit4_13.htm EX-4.13 102833
3 EXHIBIT 4.14 exhibit4_14.htm EX-4.14 37609
4 EXHIBIT 4.15 exhibit4_15.htm EX-4.15 17221
5 EXHIBIT 4.16 exhibit4_16.htm EX-4.16 39538
6 EXHIBIT 5.1 exhibit5_1.htm EX-5.1 16377
7 EXHIBIT 23.1 exhibit23_1.htm EX-23.1 4544
8 GRAPHIC image001.jpg GRAPHIC 2381
9 GRAPHIC image002.jpg GRAPHIC 6089
  Complete submission text file 0001513162-18-000248.txt   679146
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: S-8 | Act: 33 | File No.: 333-227653 | Film No.: 181099781
SIC: 8071 Services-Medical Laboratories